Drugmakers Argue Carve-Out Case Before Supreme Court

U.S. Supreme Court Justices sharply questioned drug industry attorneys Dec. 5 as the court prepares to define the FDA’s authority in accepting and challenging brand drugmakers’ patent use codes for products.
Washington Drug Letter